Ibrahim, T. S., Malebari, A. M., & Mohamed, M. F. A. (2021). Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors. MDPI AG.
Cita Chicago Style (17a ed.)Ibrahim, Tarek S., Azizah M. Malebari, y Mamdouh F. A. Mohamed. Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors. MDPI AG, 2021.
Cita MLA (8a ed.)Ibrahim, Tarek S., et al. Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.